Intrinsiqs

Is Corcept Therapeutics Incorporated overvalued?

Corcept Therapeutics Incorporated (CORT) — key valuation metrics and fundamentals.

No verdict
Price
$72.94
Fair value
—
Current P/E
—
Normal P/E
22.3
Market cap
$7.98B
Dividend yield
0.0%
Return on equity
22.9%
Sector
Healthcare

See the full interactive analysis →

Fair value compares CORT's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.

Related stocks

LLY Eli Lilly and CompanyJNJ Johnson & JohnsonABBV AbbVie Inc.RHHBY Roche Holding AGUNH UnitedHealth Group IncorporatedMRK Merck & Co., Inc.